Digital Edition: MedTech Strategist May 2022, Vol. 9, No. 5

article image
ARTICLE SUMMARY:

Movano's strategy from the outset was to position itself as a medical device company and to seek FDA clearance for its wearable products. Read our interview with CEO John Mastrototaro inside. Neuroelectrics CEO Ana Maiques talks about developing her company's precision brain stimulation therapy and the need for greater diversity in the medtech C-suite. Plus a look at Sonder Capital, a VC firm with deep roots in the device industry, and profiles of CurvaFix, EvoEndo, and Onera Health.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: